Montelione Nunzio, Catanese Vincenzo, Gabellini Teresa, Codispoti Francesco Alberto, Nenna Antonio, Spinelli Francesco, Stilo Francesco
Division of Vascular Surgery, Department of Medicine and Surgery, University Hospital Foundation Campus Bio-Medico, 00128 Rome, Italy.
Vascular Surgery Training School, Department of Translational Medicine and for Romagna, University of Ferrara, 44124 Ferrara, Italy.
Diagnostics (Basel). 2022 Nov 29;12(12):2986. doi: 10.3390/diagnostics12122986.
To report early and mid-term outcomes of the arterialization of the deep venous system in no-option critical limb-threatening ischemia (CLTI) using duplex ultrasound and angiographic evaluation to improve limb perfusion.
A single-center prospective study of patients with no-option CLTI treated with hybrid surgical arterialization of the deep venous circulation and staged endovascular embolization of the venous collateral. Embolization was performed using a controlled-release spiral, within two weeks after bypass surgery. Patients were assessed for clinical status, wound healing, median transcutaneous partial pressure of O (TcPO), and post-operative duplex ultrasound evaluating peak systolic velocity (PSV), end diastolic velocity (EDV), and resistance index (RI) to assess foot perfusion and bypass features. Primary endpoint analysis was primary technical success, limb salvage, patency rates, and clinical improvement. Secondary endpoints were 30-day and long-term mortality, major cardiovascular events (MACE), including myocardial infarction or stroke, and serious adverse events (SAE).
Five patients with no-option CLTI were treated at our center using the hybrid deep vein arterialization technique. Clinical stage was grade 3 in one patient and grade 4 in the remaining four. Mean age was 65.8 years (range 49-76 years), and two patients were affected by Buerger's disease. Primary technical success was achieved in all patients, and all the bypasses were patent at the angiographic examination. At 30-day and at average follow-up of 9.8 months (range 2-24 months), mortality, major cardiovascular events (MACE), and serious adverse events (SAE) were not reported, with a primary patency and limb salvage rates of 100%. Three patients required minor amputation. Clinical improvement was demonstrated in all patients with granulation, resolution of rest pain, or both. Median TcPO values rose from 10 mm Hg (range 4-25) before the procedure to 35 (range 31-57) after surgery, and to 59 mm Hg (range 50-76) after the staged endovascular procedure.
In our initial experience, the arterialization of the deep venous circulation, with subsequent selective embolization of the venous escape routes from the foot, seems a feasible and effective solution for limb salvage in patients with no-option CLTI and those in the advanced wound, ischemia, and foot infection (WIfI) clinical stage.
报告在无可选择的严重肢体威胁性缺血(CLTI)患者中,采用双功超声和血管造影评估来改善肢体灌注的深静脉系统动脉化的早期和中期结果。
对无可选择的CLTI患者进行单中心前瞻性研究,采用混合手术进行深静脉循环动脉化,并对静脉侧支进行分期血管内栓塞。栓塞在旁路手术后两周内使用控释螺旋圈进行。评估患者的临床状况、伤口愈合情况、经皮氧分压(TcPO)中位数,以及术后双功超声评估收缩期峰值流速(PSV)、舒张末期流速(EDV)和阻力指数(RI),以评估足部灌注和旁路特征。主要终点分析包括主要技术成功、肢体挽救、通畅率和临床改善情况。次要终点为30天和长期死亡率、主要心血管事件(MACE),包括心肌梗死或中风,以及严重不良事件(SAE)。
我们中心使用混合深静脉动脉化技术治疗了5例无可选择的CLTI患者。临床分期1例为3级,其余4例为4级。平均年龄65.8岁(范围49 - 76岁),2例患者患有血栓闭塞性脉管炎。所有患者均取得主要技术成功,血管造影检查时所有旁路均通畅。在30天及平均9.8个月(范围2 - 24个月)的随访中,未报告死亡率、主要心血管事件(MACE)和严重不良事件(SAE),主要通畅率和肢体挽救率均为100%。3例患者需要进行小截肢。所有患者均表现出临床改善,有肉芽形成、静息痛缓解或两者皆有。经皮氧分压中位数从术前的10 mmHg(范围4 - 25)升至术后的35(范围31 - 57),在分期血管内手术后升至59 mmHg(范围50 - 76)。
根据我们的初步经验,深静脉循环动脉化,随后对足部的静脉逃逸路径进行选择性栓塞,对于无可选择的CLTI患者以及处于晚期伤口、缺血和足部感染(WIfI)临床阶段的患者来说,似乎是一种可行且有效的肢体挽救解决方案。